Fresenius Fights $11.5M Atty Fee Bid In Medicare Case

Law360 (October 30, 2020, 6:42 PM EDT) -- Dialysis services company Fresenius has urged a Massachusetts federal judge to reject a whistleblower's request for $11.5 million in attorney fees and costs as part of a suit claiming the company billed Medicare for unnecessary tests on patients.

Fresenius Medical Care North America on Thursday shot back at a bid for legal fees and costs from former area manager Christopher Drennen, arguing that he didn't actually succeed on his False Claims Act allegations "in any way."

While Drennen initially had claims related to three laboratory tests, he "was forced to abandon in total claims about two of the three tests," the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!